Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Ebinger
Timothy D Henry

Showing results (321-330 of 605) with videos related to

Pageof 61
Sort By:
Circulation|September 21, 2011
Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarctionMichael D Miedema, Marc C Newell, Sue Duval, et al.
American Heart Journal|September 10, 2010
Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarctionJay H Traverse, David H McKenna, Karen Harvey, et al.
Circulation. Cardiovascular Quality and Outcomes|December 7, 2020
Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care PatientsJacob C Jentzer, Patrick R Lawler, Sean van Diepen, et al.
Nature Clinical Practice. Cardiovascular Medicine|October 26, 2006
Primer: practical approach to the selection of patients for and application of EECPAndrew D Michaels, Peter A McCullough, Ozlem Z Soran, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 4, 2020
Cardiac procedural deferral during the coronavirus (COVID-19) pandemicCelina M Yong, Lawrence Ang, Frederick G P Welt, et al.
Circulation|July 16, 2003
Clinical, angiographic, and interventional follow-up of patients with aortic-saphenous vein graft connectorsJay H Traverse, Michael R Mooney, Wesley R Pedersen, et al.
American Heart Journal|September 21, 2015
Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United StatesTracy Y Wang, Timothy D Henry, Lisa A McCoy, et al.
Circulation|February 26, 2015
Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart AssociationJeffrey B Washam, Charles A Herzog, Amber L Beitelshees, et al.
European Heart Journal|November 2, 2011
Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfersDavid M Larson, Sue Duval, Scott W Sharkey, et al.
Circulation|May 22, 2015
Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) StudyYing Xian, Tracy Y Wang, Lisa A McCoy, et al.
Pageof 61

Showing results (321-330 of 605) with videos related to

Sort By:
Pageof 61
Circulation|September 21, 2011
Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarctionMichael D Miedema, Marc C Newell, Sue Duval, et al.
American Heart Journal|September 10, 2010
Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarctionJay H Traverse, David H McKenna, Karen Harvey, et al.
Circulation. Cardiovascular Quality and Outcomes|December 7, 2020
Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care PatientsJacob C Jentzer, Patrick R Lawler, Sean van Diepen, et al.
Nature Clinical Practice. Cardiovascular Medicine|October 26, 2006
Primer: practical approach to the selection of patients for and application of EECPAndrew D Michaels, Peter A McCullough, Ozlem Z Soran, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 4, 2020
Cardiac procedural deferral during the coronavirus (COVID-19) pandemicCelina M Yong, Lawrence Ang, Frederick G P Welt, et al.
Circulation|July 16, 2003
Clinical, angiographic, and interventional follow-up of patients with aortic-saphenous vein graft connectorsJay H Traverse, Michael R Mooney, Wesley R Pedersen, et al.
American Heart Journal|September 21, 2015
Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United StatesTracy Y Wang, Timothy D Henry, Lisa A McCoy, et al.
Circulation|February 26, 2015
Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart AssociationJeffrey B Washam, Charles A Herzog, Amber L Beitelshees, et al.
European Heart Journal|November 2, 2011
Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfersDavid M Larson, Sue Duval, Scott W Sharkey, et al.
Circulation|May 22, 2015
Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) StudyYing Xian, Tracy Y Wang, Lisa A McCoy, et al.
Pageof 61